Introduction
Designing and preparation of appropriate delivery systems for biomacromolecules such as genes, proteins, polypeptides remains a major challenge in the field of drug delivery system development 1 .The application of nanoparticles transferring system as vaccine carrier could potentially overcome limitations of subunit vaccines by increasing the antigen surface area, enhancing the stability of proteins, stabilizing the biological activity of antigens/proteins and augmenting the solubility of the antigen/protein complexes. Moreover, nanoparticles could prolong the systemic circulation time of
antigens by processes such as encapsulation, which protects the active segments of antigens from endogenous enzyme degradation while promotes local accumulation. In addition, by employing nanoparticles as vaccine carriers, controlled and sustained release of antigens accompanied by other immune modulators can be achieved, which is essential to potent immune responses and lasting immune memory. In addition, studies have shown that nanoparticles can stimulate dendritic cell (DC) maturation and antigen presentation, both of which are crucial for the initiation of effective immune responses 2, 3 . Moreover, -it has been shown that nanoparticles can stimulate immune responses, and that their compatibility with the immune system are mainly dependent on surface chemical reactivity of the nanoparticles. Reducing the immune toxicity of nanoparticles could make them useful platforms for drug delivery 4 .
Limited by their biological characteristics, biomacromolecules are easily degraded in vivo resulting in low bioavailability. As a result, for biomacromolecules delivery, polymer nanocarriers have often been used 5 
Synthesis of 3s-PLGA-PO-PEG
The synthetic route of 3s-PLGA-PO-PEG was depicted as follow. The 3s-PLGA was firstly synthesized using lactide and glycolide by ring-opening polymerizationas previously reported 14 .The block copolymer was obtained when modified 3s-PLGA and PEG linked with oxalyl chloride by acylation reaction. Three-arm PLGA connected to PEG by peroxalate ester bond which breaks in the presence of H2O2. were prepared using the above describe method for the purpose of tracking.
Preparation and characterization of NPs modified with HA
The average particle size, encapsulation and loading capacity and surface morphology were determined to evaluate the characteristics of NPs. The particle size, size distribution and surface charges of the NPs were determined by photon correlation spectroscopy (PCS)using Nano-ZS ZEN3600 (Malvern Instruments). Morphological 
The scavenging ability of H2O2 by NPs in vitro
The scavenging ability of H2O2 by NPs was measured as follows. 
Dendritic cells viability assays
To evaluate the potential cytotoxicity of NPs on cells, we performed a MTT assay of cells treated with soluble OVA or NPs. DC 2.4 cells were cultured in RPMI1640 with 10% FBS, 100 μg/mL penicillin, 100 μg/mL streptomycin under 5% CO2 at 37°C. They were seeded in96-well plates in 100 μL medium per well at a density of 5×10 4 cells/mL for 24 h and then cells were washed and incubated for another 24 h with 100 μL of medium-containing free OVA or NPs. Then, the NP-containing medium was removed.
0.5mg/mL MTT solution in medium was added and kept for 4 h. At last, the supernatant was removed and 150 μL DMSO was added. Cells were covered with tinfoil and agitated on orbital shaker for 15 min. Absorbance was read at 490 nm with a reference filter of 630 nm using a microplate reader (Varioskan Flash 3001, Thermo, USA). Zeiss, Jena, Germany)
Intracellular uptake of

Bone marrow dendritic cells (BMDCs) stimulation and maturation
BMDCs which were isolated from C57BL/6J mice femurs and tibias. Erythrocytes were lysed by red cell lysing reagent. BMDCs were then cultured in complete RPMI1640 medium containing 20 ng/mL GM-CSF and 10 ng/mL IL-4 for 6 d to obtain immature DCs 16 .The immature DCs were treated with free OVA (20 μg/mL) and OVA-loaded NPs for 24h. The levels of surface markers expression were observed by flow cytometry.
The DCs were stained with anti-mouse CD11c, CD40, CD86 and CCR7 monoclonal antibodies for 30 min at 4 °C in the dark. Cells were washed twice and then analyzed by flow cytometry using a BD Accuri™ C6 flow cytometer (BD Biosciences, San Jose, CA).
Antigen cross presentation in vitro
In vitro antigen cross presentation by DCs was evaluated by B3Z T cell activation assay 17 .Immature BMDCs were harvested and pulsed with free OVA or OVA loaded NPs in a 24-well plate for 8 h at 37 °C. BMDCs were washed and then cocultured with B3Z T cells at a density of 5 ×10 5 cells/well which is the CD8 + T cell hybridoma presented by MHC class I molecules overnight. X-Gal substrate (1.5 mg/mL of X-Gal， 0.25% PBS-NP40) was added to the remaining cells and then incubated for 24 h. Finally, the positive signal was measured by a microplate reader (Thermo) at 405 nm.
In vivo trafficking of cyanine 7-labeled NPs
To investigate the effect of nanovaccines on lymphatic trafficking in vivo, OVA was labeled by near infrared (NIR) fluorescent Cyanine 7 dyes. C57BL/6 mice were administrated by subcutaneous (s.c) injection at the tail base site and OVA-Cy7 and OVA-Cy7 NPs were then visualized at the injection site and the inguinal lymph nodes 18 .
Cy7 fluorescent signals at different time (0, 6, 12, 24 h) was measured by Maestro imaging system (CRI, USA). Fluorescence quantitative change was measured by quantifying the fluorescent intensity.
In vivo immunization, antibody production and in vitro T cell proliferation assay
Six-to-eight-week-old female C57BL/6J mice (4 mice/group) were immunized with OVA or OVA-loaded NPs (20 μg OVA/mouse) by subcutaneous injection at a 2-week interval for three times. As for antibody production analysis, blood was collected 7 days after last immunization, OVA specific IgG, IgG1, IgG2a antibody in serum were determined by ELISA (eBioscience).
Seven days post last immunization, splenocytes (1×10 6 cells/mL) were isolated and stimulated with OVA (20 μg/mL) in a 24-well plate for 72 h. The production of IL-6 in supernatants was measured by ELISA kit. To determine T lymphocytes proliferation, splenocytes were isolated and stained with 5 μmol/L CFSE (Sigma-Aldrich). After antimouse CD3 and anti-mouse CD28 immobilized in a 24-well plate, the CFSE-dyed T cells (1×10 6 cells/mL) were incubated with 20 μg/mL soluble OVA for 72h. Finally, the cells were labeled with PE-anti-mouse CD4 or PE-anti-mouse CD8, and decreased CFSE intensity was determined to observe different T cell proliferation using flow cytometry. 
T cell activation response in vivo
Statistical analysis
The quantitative data were presented as mean ± S.D. Statistical significance were analyzed using a student's T-Test (*P<0.05; **P<0.01; ***P<0.001).
Results and discussion
Characterization of NPs
NPs were prepared by a double emulsion (W1/O/W2) solvent evaporation method. Table 1 ). The results of TEM and Dynamic Light Scattering showed that all groups of NPs exhibited dispersed spherical shape of similar size (Fig. 1B) .
The protein capsulation efficiency (EE) and loading capacity (LC) were listed in Table   1 . We found that PEGylation increased OVA loading likely due to the hydrophilicity of PEG. In addition, HA modification also increased viscosity of NPs and protein adhesion.
The stability of the NPs was then investigated. Our results observed no evident morphological changes of all groups of NPs for 21 days at 4 ℃，indicating suitable stability of the NPs (Fig. 1C) .
It has been demonstrated that PEG fragments not only increase the stability of NPs, but also reduce proteolysis, both of which result in increased circulation time and improved efficacy 20 .Since HA is a member of the mucopolysaccharide family with high viscosity that may attenuate protein release, we have also examined the protein releasing ability of the NPs (Fig. 1D) . We observed sustained OVA release from all OVA-loaded NPs in PBS (pH 7.4) for 21 days. A burst release of more than 20% was detected during the first day for P-O and PO, followed by a slower and continued release for 20 days. In contrast, OVA were released from the PHO NPs in a slower manner compared to the P-O and PO groups, mainly due to the viscosity of the HA coatings.
Given that smaller particles (20-200 nm) tend to accumulate within the LN-resident
DCs and other monocytic APCs 21 ,our NPs could potentially be effective nanovaccine delivery vehicles considering their narrow size distribution, high encapsulation efficiency, stability and sustained antigen-releasing property.
Hydrogen peroxide responsiveness of NPs in vitro
It has been known that the peroxyl oxalic easter bonds, which connect the PLGA and PEG segments of the 3s-PLGA-PO-PEG NPs, are sensitive to H2O2. In the presence ofH2O2, breakage of the PO bonds would lead to degeneration of the NPs. To assess the responsiveness and the scavenging H2O2 property of the NPs by the amplex red hydrogen/peroxidase assay 22 .As shown in Fig. 2A , the concentrations of remaining determined by the MTT assay. The values shown are mean ± SD (n=3). *P < 0.05, **P < 0.01 and ***P < 0.001 to control.
In vitro stability and toxicity of NPs
To determine in vitro stability and toxicity of the NPs, cell viability was assessed using a dendritic cell line (DC 2.4). Cell viability was performed using the MTT assay after cells were treated with a series of NPs ranging from 12.5 μg/mL to 400 μg/mL. Cell Bars shown are mean ± SD (n=3). *P < 0.05, **P < 0.01 and ***P < 0.001 to OVA groups. DC maturation is critical to T cell and immune response activation, we have further investigated the effect of NPs on DC maturation in vitro using bone marrow derived DCs (BMDCs). Thus, immature BMDCs were harvested on day 7 and exposed to NPs for 24h. Both PO and PHO NPs enhanced the expression of CD40 and CD86 (Fig. 5A,   B ), indicating their capability of promoting DC maturation.
Antigen cross-presentation is another step following antigen uptake and DC maturation, during which DCs present the processed antigens to CD4 + or CD8 + T cells through the MHC class II or MHC class I pathways, respectively. To measure the effects of NPs on antigen presentation, BMDCs were pulsed with free OVA or NP-formulated OVA for 24 h, and co-cultured with OVA-responsive B3Z T cells hybridoma overnight. Indeed, the LacZ B3Z T cells are sensitive to OVA class I epitope SIINFEKL that is known to be presented by the MHC class I H-2Kb on DCs and are able to generate β-galactosidase upon antigen recognition, concentrations of β-galactosidase were quantified from all tested groups 23 . As shown in Fig.5C ,P-O NPs significantly enhanced the value of OD 405 by 2folds compared to free OVA, indicating OVA-specific CD8 + T cell activation.
PO and PHO NPs also induced significantly elevated CD8 + T cell activation than free OVA. It has been known that endogenous antigens are often presented via the MHC class I pathway, while exogenous antigens are presented via the MHC class II pathway 24 .Since our results showed up-regulation of CD8 + T cell activation following exposure to NP-delivered OVA, it could be said that NPs promoted antigen cross presentation possibly due to enhanced DC phagocytosis, antigen release and lysosomal 22 escape that had been observed with the ROS-responsive NPs. Cytokine release by mature DCs is also important for the induction of local immune responses. We have also measured cytokine productions in supernatants of BMDCs that had been cocultured with NP-delivered OVAs. As shown in Fig. 5D , E, BMDCs secreted significantly more IL-6 and TNF-α following NPs stimulation compared to free OVA, consistent with a pro-inflammatory role of the NP-delivered OVAs.
Our results indicate that NPs promoted antigen uptake, DC maturation and crosspresentation, accompanied by pro-inflammatory cytokine production compared to free OVA. However, no significant differences could be detected among different composition of the NPs, which could mean that the PLGA NPs themselves were a potent adjuvant. Indeed, previous studies have reported adjuvant property of PLGA, consistent with our results 25 . The values were mean ± SD (n=3).*P < 0.05, **P < 0.01 and ***P < 0.001 to soluble OVA.
Nanovaccine enhances antigen in vivo trafficking
As an important immune organ, lymph nodes will uptake antigen by DCs or macrophages to activate immune response. Antigens are expected to migrate to the draining lymph nodes and NP in vivo trafficking has been used as an indicator to monitor vaccine delivery. It has been reported that smaller particles were more often found in lymph nodes while larger particles were more efficiently phagocytosed by (Fig. 6B) , which could be due to increased DC targeting property of the NPs as a result of HA modification. We also monitored the fluorescence signals for more than 1 week with attenuated fluorescence intensity detectable as time extended.
Nevertheless, we found that administration of NPs would result in slow accumulation and retention of OVA in the LNs compared to soluble OVA (Fig. S1 ).
Nanovaccine enhanced in vivo T cell activation and antibody production
Six-week old female C57BL/6J mice were immunized with OVA or OVA-loaded NPs (20 μg OVA/mouse) as detailed in the Methods section. Splenocytes were then isolated 7 days after the last immunization and labeled appropriately as previously reported for T-cell proliferation study 27 . We found that mice immunized with PO and PHO NPs had elevated numbers of spleen CD8 + T cells than other groups (Fig. 7A, B) . Up-regulation of CD4 + T cell number was also observed in mice treated with PO NPs ( IgG1 and IgG2a production more than other NPs and free OVA. It is known that in mice, Th1 T cell activation will often produce IgG2a antibody whilst Th2 T cell activation would likely induce IgG1 antibody generation 30 .As a result, since elevation of both IgG2a and IgG1 antibodies was observed, the PHO NPs would likely promote both Th1
and Th2 cell immune response in vivo. In addition, elevated IL-6 production was also observed in splenocytes extracted from mice treated with PHO NPs, confirming a potent role of the PHO NPs in promoting immune cells proliferation, differentiation and CTL response induction. . The values are mean ± SD (n=3). *P < 0.05, **P < 0.01 and ***P < 0.001 to soluble OVA.
Nanovaccines enhanced memory T cell proliferation in vivo
Memory T cell responses were measured by lymph node homing receptors. According 
Conclusions
In the present study, we have designed a ROS-triggered 3s-PLGA-PO-PEG nanoparticle-based antigen delivery system with HA modification that targets the CD44 receptors on DC surface (PHO NPs). We found that the PHO NPs enhanced dendritic cell maturation, antigen uptake, lysosomal escape and antigen presentation in vitro.
PHO NPs also robustly promoted OVA-specific antibody production while stimulated antigen-induced both CD4 + and CD8 + T cell responses as well as memory T cells (Fig.9 ).
In summary, the ROS-triggered nanoparticle-based antigen delivery system could enhance vaccine-induced cellular and humoral immune responses and may be a promising candidate as a novel vaccine. 
